Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.43 Analyst target: $10.00 Upside: 599.30%
Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.